Speed is the key when planning of vaccines, and in particular those who with this fight, flu, and specifically the H1N1 chain, which began the hard world hit in 2009. A tactical reaction awarded this week of health and human two contracts for the company now to the vaccines for pandemic and the seasonal influenza outbreaks make faster available U.S. Department services (HHS). Contracts for advanced development of new types of vaccine be 215 million total.
HHS received a contract of Novavax, Inc., Rockville, Maryland, from 97 million in the first three years, which may be extended by two years for a total value of 179.1 million. HHS supplement separate VaxInnate, Inc. of Cranbury, n.j., 117,9 million in the first three years, another for two years, for a total value of $ 196.6 million be extended can.
HHS Kathleen Sebelius Secretary said:
"The pandemic (H1N1) 2009 has shown the need for technologies that can provide vaccines faster." "This next-generation influenza vaccines hold the potential more effectively, making the first and last doses vaccine sooner than the vaccines against existing flu after weeks and months during a pandemic as well as in an outbreak of influenza can save more lives."
In April 2009 was an outbreak of influenza, the Mexico and the United States; the CDC has seven cases of the new flu A/H1N1. April 24, it became clear that the outbreak of the ILI in Mexico and confirmed new flu cases in the Southwest was, that we are associated and issued a health advisory on the introduction of "flu like illness in the United States and in the Mexico." Then the disease can the number of confirmed cases in the amount of 2 fast, 099 on 7, despite the aggressive action to stop by the Mexican Government, the spread of the disease.
June 11, 2009, pandemic flu H1N1 declared, move the level of warning in phase 6, marking the first global pandemic since 1968 Hong Kong flu. The World Health Organization, said the new strain of origin H1N1 swine as a pandemic. This variety is often called swine flu by public media. New virus spread all over the world and had about 17,000 deaths beginning 2010. 10. August 2010, explained the World Health Organization H1N1 flu pandemic, say that influenza activity in the world to typical returned was seasonal.
October 25, 2009 President Barack Obama declared H1N1 flu us formally a national emergency.
Under his contract, Novavax, the development is new technologies to produce vaccines with insect cells to promote expressions flu proteins and virus-like particles, a strong immune response in humans.
VaxInnate developed to protect technology for influenza vaccine, recombinant based on the combination of proteins of flu and bacteria promote the immune response against the flu.
The contracts are part of a strategy of national pandemic vaccine preparation, including the development of new vaccines against flu as well as expand and diversify domestic flu vaccine production as well as development and testing of the stock of pre-pandemic vaccine.
19. August 2010, HHS published a review of the system of the Federal Government Secretary Kathleen Sebelius to produce medical countermeasures and recommendations for a better approach. The recommendations include the development of very fast, flexible and innovative technologies to increase the capacity to produce vaccines against pandemic influenza and other threats in much less time.
These recommendations are consistent with a report of the Council of Advisor to the President for science and technology, "report of the President on the restructuring of the production of companies for the challenges of the pandemic influenza influenza.' The two reports are available here.
Source: U.S. Department of health and human services